Ghent University Academic Bibliography

Advanced

The VEGFR inhibitor cediranib improves the efficacy of fractionated radiotherapy in a colorectal cancer xenograft model

Elodie Melsens, Bert Verberckmoes, NATACHA ROSSEEL, Christian Vanhove UGent, Benedicte Descamps UGent, Piet Pattyn UGent and Wim Ceelen UGent (2017) EUROPEAN SURGICAL RESEARCH . 58. p.95-108
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
keyword
Surgery
journal title
EUROPEAN SURGICAL RESEARCH
Eur Surg Res
volume
58
pages
95 - 108
publisher
S. Karger AG
ISSN
0014-312X
1421-9921
DOI
10.1159/000452741
language
English
UGent publication?
yes
classification
A1
id
8502493
handle
http://hdl.handle.net/1854/LU-8502493
date created
2017-01-17 10:46:39
date last changed
2017-01-19 09:47:57
@article{8502493,
  author       = {Melsens, Elodie and Verberckmoes, Bert and ROSSEEL, NATACHA and Vanhove, Christian and Descamps, Benedicte and Pattyn, Piet and Ceelen, Wim},
  issn         = {0014-312X},
  journal      = {EUROPEAN SURGICAL RESEARCH                                        },
  keyword      = {Surgery},
  language     = {eng},
  pages        = {95--108},
  publisher    = {S. Karger AG},
  title        = {The VEGFR inhibitor cediranib improves the efficacy of fractionated radiotherapy in a colorectal cancer xenograft model},
  url          = {http://dx.doi.org/10.1159/000452741},
  volume       = {58},
  year         = {2017},
}

Chicago
Melsens, Elodie, Bert Verberckmoes, NATACHA ROSSEEL, Christian Vanhove, Benedicte Descamps, Piet Pattyn, and Wim Ceelen. 2017. “The VEGFR Inhibitor Cediranib Improves the Efficacy of Fractionated Radiotherapy in a Colorectal Cancer Xenograft Model.” European Surgical Research  58: 95–108.
APA
Melsens, E., Verberckmoes, B., ROSSEEL, N., Vanhove, C., Descamps, B., Pattyn, P., & Ceelen, W. (2017). The VEGFR inhibitor cediranib improves the efficacy of fractionated radiotherapy in a colorectal cancer xenograft model. EUROPEAN SURGICAL RESEARCH  , 58, 95–108.
Vancouver
1.
Melsens E, Verberckmoes B, ROSSEEL N, Vanhove C, Descamps B, Pattyn P, et al. The VEGFR inhibitor cediranib improves the efficacy of fractionated radiotherapy in a colorectal cancer xenograft model. EUROPEAN SURGICAL RESEARCH  . S. Karger AG; 2017;58:95–108.
MLA
Melsens, Elodie, Bert Verberckmoes, NATACHA ROSSEEL, et al. “The VEGFR Inhibitor Cediranib Improves the Efficacy of Fractionated Radiotherapy in a Colorectal Cancer Xenograft Model.” EUROPEAN SURGICAL RESEARCH  58 (2017): 95–108. Print.